Dec 2, 2025, 01:25
Exploring AI’s Role in IVF Workflow – Future Fertility
Future Fertility shared a post on LinkedIn:
“This week, we’re highlighting a CFAS 2025 abstract exploring how Canadian fertility professionals view the role of AI in IVF care. The study captured perspectives from 23 clinicians and embryologists through 1:1 interviews to understand opportunities, challenges, and priority areas for responsible AI adoption in the IVF workflow.
What did they tell us?
- AI is seen as a promising way to bring more consistency to complex clinical and laboratory decisions.
- Clinicians and embryologists emphasized the importance of scientific validation, usability, and ethical, patient-centred implementation.
- Many identified practical applications — from gamete assessment and cycle management to lab workflow optimization and quality control.
- Many stressed the need for transparent communication and clinician-guided interpretation of AI outputs to support patient care.
Why this matters
- Integrating AI into IVF isn’t just about technology — it’s about aligning tools with real-world clinical workflows, patient expectations, and the professional judgment of those delivering care.
- Understanding frontline perspectives is essential to ensuring AI enhances clinician and embryologist expertise.
What’s next?
- These insights are informing the next phase of our research, where we’ll continue capturing professional perspectives on these topics at scale through a short 10-min survey.
Clinicians and Embryologists in Canada: We’d love to hear from you!
- For every eligible completed survey, Future Fertility will donate $30 to Fertility Friends Foundation, helping expand access to fertility treatment.
Read the full abstract.
- Authors: Laís Vanzella, Kirsten Anwender, Justin Kirkey, Natalie Mercuri, Dan Nayot, Jullin Fjeldstad
- This study was generously supported by Ferring Pharmaceuticals Canada.”

Stay updated on all scientific advances in the field of fertility with Fertility News.
AI in IVF
Canadian Fertility Professionals
CFAS 2025
Dan Nayot
Embryologists
Ethical Considerations
Ferring Pharmaceuticals
Fertility
Fertility News
fertility research
Fertility treatment
Future Fertility
IVF Workflow
Jullin Fjeldstad
Justin Kirkey
Kirsten Anwender
Laís Vanzella
Natalie Mercuri
Patient-Centred Implementation
Responsible AI Adoption
-
Nov 2, 2026, 17:08Elena Milner: The 2nd Class of the School of Embryology Is Already in Full Swing
-
Nov 2, 2026, 17:05November Is National Diabetes Month – PCOS Awareness Association
-
Nov 2, 2026, 17:04Thanos Papathanasiou: Are We Preparing Patients for the IVF Cycle, or for the IVF Journey?
-
Nov 2, 2026, 17:02Anna Morales: Why Is It So Hard to Build in Women’s Health?
-
Nov 2, 2026, 16:59Rickard Ericsson: Honored to Take on the Role of Interim CEO of the Vitrolife Group
-
Nov 2, 2026, 16:56Mohammed Nasur: 1 Small Simulation, A Bigger Purpose
-
Nov 2, 2026, 16:54Carlos Guerrero: Presenting Our Latest Research on AI and Embryo Assessment at ASRM 2026
-
Nov 2, 2026, 16:52Sarah Lewen: My 1st ASRM Is Officially Complete
-
Nov 2, 2026, 16:49Jemma Garratt: Taking on the Role of Kind IVF and Data Science Manager at London Women’s Clinic
